Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model

Radiology. 1998 Jun;207(3):657-62. doi: 10.1148/radiology.207.3.9609887.

Abstract

Purpose: To investigate how reduction in cardiac output affects the magnitude and timing of aortic and hepatic contrast medium enhancement during abdominal computed tomography (CT).

Materials and methods: Eight 20-30-kg pigs underwent CT before and after pharmacologic reduction of cardiac output (measured by means of thermodilution). Each CT study consisted of 53 dynamic images acquired every 5 seconds at a fixed level through the midliver after intravenous injection of contrast medium (concentration, 282 mg of iodine per milliliter; dose, 2 mL per kilogram of body weight; injection rate, 2 mL/sec). Curves of contrast medium enhancement versus time were measured. Changes in the magnitude and timing of aortic and hepatic enhancement were compared with the reduction in cardiac output.

Results: With reduction in cardiac output, the time from the injection start to the arrival of the contrast medium bolus in the aorta (P < .01) and the times from injection completion to peak aortic (P < .01) and peak hepatic (P < .01) enhancement increased. As cardiac output decreased, peak aortic enhancement increased proportionally (P < .01). Peak hepatic enhancement increased only slightly and correlated weakly with the decrease in cardiac output (P = .07).

Conclusion: As cardiac output decreases, the times to the arrival of the contrast medium bolus in the aorta and to peak aortic and hepatic enhancement increase. Reduction in cardiac output results in a substantial increase in peak aortic enhancement but not in peak hepatic enhancement.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aortography* / instrumentation
  • Aortography* / methods
  • Calcium Channel Blockers / pharmacology
  • Cardiac Output* / drug effects
  • Catheterization, Swan-Ganz
  • Contrast Media* / pharmacokinetics
  • Liver / diagnostic imaging*
  • Swine
  • Thermodilution
  • Time Factors
  • Tomography, X-Ray Computed* / instrumentation
  • Tomography, X-Ray Computed* / methods
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Contrast Media
  • Verapamil